FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis

BACKGROUND: Several clinical trials have demonstrated the safety and effectiveness of oral tenofovir disoproxil fumarate (TDF), with or without emtricitabine (FTC), as pre-exposure prophylaxis (PrEP) for reducing the risk of HIV acquisition. Adherence to the study product was insufficient to demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Corneli, Amy L., Deese, Jennifer, Wang, Meng, Taylor, Doug, Ahmed, Khatija, Agot, Kawango, Lombaard, Johan, Manongi, Rachel, Kapiga, Saidi, Kashuba, Angela, Van Damme, Lut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:
Epidemiology and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059551/
https://www.ncbi.nlm.nih.gov/pubmed/25157647
http://dx.doi.org/10.1097/QAI.0000000000000158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059551/
https://www.ncbi.nlm.nih.gov/pubmed/25157647
http://dx.doi.org/10.1097/QAI.0000000000000158

Ejemplares similares